GLP-1 Receptor Agonists Prevent Vascular Aging by Modulating Stem Cell Exhaustion and Chronic Inflammation

Despite the established cardiovascular benefits of Glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes and obesity, the precise mechanisms underlying their cardioprotective effects are still being fully elucidated. Current standard-of-care often addresses symptoms but struggles with the underlying progression of vascular aging, a critical factor in conditions like atherosclerosis, heart failure, and peripheral artery disease. This review highlights a novel paradigm: GLP-1RAs' ability to counteract vascular aging by influencing regenerative progenitor cells, offering a deeper understanding of their pleiotropic actions beyond glycemic control.

This comprehensive review synthesized recent evidence demonstrating the efficacy of GLP-1RAs in treating various cardiometabolic conditions, including atherosclerosis, heart failure, and peripheral artery disease. The authors focused on studies that reported GLP-1RA effects on vascular regenerative progenitor cell flux, integrating findings related to three classical hallmarks of vascular aging: stem cell exhaustion, altered intercellular communication, and chronic systemic inflammation. The review specifically explored how imbalances in hematopoiesis during cardiometabolic diseases intersect with the senescence-associated secretory phenotype (SASP) to accelerate vascular aging.

GLP-1RAs effectively shift the balance from damage accumulation to repair competence in blood vessels prematurely aged by cardiometabolic syndrome. The review highlights that GLP-1RAs improve vascular regenerative progenitor cell flux, a critical mechanism for preventing vascular aging. This action directly addresses stem cell exhaustion, one of the key hallmarks of vascular aging, by enhancing the regenerative capacity of the vasculature. Furthermore, GLP-1RAs modulate altered intercellular communication, improving cellular crosstalk essential for maintaining vascular health and repair processes. They also significantly mitigate chronic systemic inflammation, a major driver of vascular aging, by influencing the senescence-associated secretory phenotype (SASP) and rebalancing hematopoiesis. This comprehensive action suggests a broad protective effect.

The review underscores that GLP-1RAs integrate activities that shift the balance from damage accumulation to repair competence in blood vessels prematurely aged by cardiometabolic syndrome.